Impaired T cell activation and cytokine production by calcitriol-primed human B cells

Clinical and Experimental Immunology

Volumn 178, Issue 2, 2014, Pages 364-372

  Drozdenko, G ^a   Scheel, T ^b   Heine, G ^a   Baumgrass, R ^b   Worm, M ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b DEUTSCHES RHEUMA FORSCHUNGSZENTRUM   (Germany)

Author keywords

B cells; Co stimulatory molecules; T cells; Vitamin D

Indexed keywords

CALCITRIOL; CD28 ANTIGEN; CYTOKINE; MONOCLONAL ANTIBODY;

B LYMPHOCYTE; BIOSYNTHESIS; CELL CULTURE; DRUG EFFECTS; GENE EXPRESSION; HUMAN; IMMUNOLOGY; IMMUNOPHENOTYPING; LYMPHOCYTE ACTIVATION; METABOLISM; T LYMPHOCYTE;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD28; B-LYMPHOCYTES; CALCITRIOL; CELLS, CULTURED; CYTOKINES; GENE EXPRESSION; HUMANS; IMMUNOPHENOTYPING; LYMPHOCYTE ACTIVATION; T-LYMPHOCYTES;

EID: 84908217264     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/cei.12406     Document Type: Article

References (45)

1. Schwartz RH. T cell anergy. Annu Rev Immunol 2003; 21:305-334.
2. Mamula MJ, Fatenejad S, Craft J. B cells process and present lupus autoantigens that initiate autoimmune T cell responses. J Immunol 1994; 152:1453-1461.
3. Rodriguez-Pinto D. B cells as antigen presenting cells. Cell Immunol 2005; 238:67-75.
4. von Bergwelt-Baildon MS, Vonderheide RH, Maecker B etal. Human primary and memory cytotoxic T lymphocyte responses are efficiently induced by means of CD40-activated B cells as antigen-presenting cells: potential for clinical application. Blood 2002; 99:3319-3325.
5. Ahmadi T, Flies A, Efebera Y, Sherr DH. CD40 Ligand-activated, antigen-specific B cells are comparable to mature dendritic cells in presenting protein antigens and major histocompatibility complex class I- and class II-binding peptides. Immunology 2008; 124:129-140.
6. Peroni DG, Piacentini GL, Cametti E, Chinellato I, Boner AL. Correlation between serum 25-hydroxyvitamin D levels and severity of atopic dermatitis in children. Br J Dermatol 2011; 164:1078-1082.
7. Brehm JM, Celedon JC, Soto-Quiros ME etal. Serum vitamin D levels and markers of severity of childhood asthma in Costa Rica. Am J Respir Crit Care Med 2009; 179:765-771.
8. Heine G, Lahl A, Muller C, Worm M. Vitamin D deficiency in patients with cutaneous lupus erythematosus is prevalent throughout the year. Br J Dermatol 2010; 163:863-865.
9. Thudi A, Yin S, Wandstrat AE, Li QZ, Olsen NJ. Vitamin D levels and disease status in Texas patients with systemic lupus erythematosus. Am J Med Sci 2008; 335:99-104.
10. Cantorna MT. Vitamin D and multiple sclerosis: an update. Nutr Rev 2008; 66:S135-138.
11. Munger KL, Levin LI, Hollis BW, Howard NS, Ascherio A. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 2006; 296:2832-2838.
12. Xystrakis E, Kusumakar S, Boswell S etal. Reversing the defective induction of IL-10-secreting regulatory T cells in glucocorticoid-resistant asthma patients. J Clin Invest 2006; 116:146-155.
13. Baeke F, van Etten E, Gysemans C, Overbergh L, Mathieu C. Vitamin D signaling in immune-mediated disorders: evolving insights and therapeutic opportunities. Mol Aspects Med 2008; 29:376-387.
14. Heine G, Anton K, Henz BM, Worm M. 1alpha, 25-dihydroxyvitamin D3 inhibits anti-CD40 plus IL-4-mediated IgE production in vitro. Eur J Immunol 2002; 32:3395-3404.
15. Heine G, Niesner U, Chang HD etal. 1, 25-dihydroxyvitamin D(3) promotes IL-10 production in human B cells. Eur J Immunol 2008; 38:2210-2218.
16. Penna G, Adorini L. 1 Alpha, 25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J Immunol 2000; 164:2405-2411.
17. Pedersen AW, Holmstrom K, Jensen SS etal. Phenotypic and functional markers for 1alpha, 25-dihydroxyvitamin D(3)-modified regulatory dendritic cells. Clin Exp Immunol 2009; 157:48-59.
18. Milovanovic M, Heine G, Hallatschek W, Opitz B, Radbruch A, Worm M. Vitamin D receptor binds to the epsilon germline gene promoter and exhibits transrepressive activity. J Allergy Clin Immunol 2010; 126:1016-1023. 23 e1-4.
19. Geldmeyer-Hilt K, Heine G, Hartmann B, Baumgrass R, Radbruch A, Worm M. 1, 25-dihydroxyvitamin D3 impairs NF-kappaB activation in human naive B cells. Biochem Biophys Res Commun 2011; 407:699-702.
20. Quah BJ, Warren HS, Parish CR. Monitoring lymphocyte proliferation in vitro and in vivo with the intracellular fluorescent dye carboxyfluorescein diacetate succinimidyl ester. Nat Protoc 2007; 2:2049-2056.
21. Harp CT, Lovett-Racke AE, Racke MK, Frohman EM, Monson NL. Impact of myelin-specific antigen presenting B cells on T cell activation in multiple sclerosis. Clin Immunol 2008; 128:382-391.
22. Fritsche J, Mondal K, Ehrnsperger A, Andreesen R, Kreutz M. Regulation of 25-hydroxyvitamin D3-1 alpha-hydroxylase and production of 1 alpha, 25-dihydroxyvitamin D3 by human dendritic cells. Blood 2003; 102:3314-3316.
23. Bartels LE, Hvas CL, Agnholt J, Dahlerup JF, Agger R. Human dendritic cell antigen presentation and chemotaxis are inhibited by intrinsic 25-hydroxy vitamin D activation. Int Immunopharmacol 2010; 10:922-928.
24. Appleman LJ, Berezovskaya A, Grass I, Boussiotis VA. CD28 costimulation mediates T cell expansion via IL-2-independent and IL-2-dependent regulation of cell cycle progression. J Immunol 2000; 164:144-151.
25. Baeke F, Takiishi T, Korf H, Gysemans C, Mathieu C. Vitamin D: modulator of the immune system. Curr Opin Pharmacol 2010; 10:482-496.
26. Griffin MD, Lutz W, Phan VA, Bachman LA, McKean DJ, Kumar R. Dendritic cell modulation by 1alpha, 25 dihydroxyvitamin D3 and its analogs: a vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo. Proc Natl Acad Sci USA 2001; 98:6800-6805.
27. Adorini L, Penna G, Giarratana N, Uskokovic M. Tolerogenic dendritic cells induced by vitamin D receptor ligands enhance regulatory T cells inhibiting allograft rejection and autoimmune diseases. J Cell Biochem 2003; 88:227-233.
28. Ferreira GB, Overbergh L, Verstuyf A, Mathieu C. 1alpha, 25-Dihydroxyvitamin D3 and its analogs as modulators of human dendritic cells: a comparison dose-titration study. J Steroid Biochem Mol Biol 2013; 136:160-165.
29. Hartmann B, Heine G, Babina M etal. Targeting the vitamin D receptor inhibits the B cell-dependent allergic immune response. Allergy 2011; 66:540-548.
30. Li J, Liu Z, Jiang S, Cortesini R, Lederman S, Suciu-Foca N. T suppressor lymphocytes inhibit NF-kappa B-mediated transcription of CD86 gene in APC. J Immunol 1999; 163:6386-6392.
31. Zou GM, Hu WY. LIGHT regulates CD86 expression on dendritic cells through NF-kappaB, but not JNK/AP-1 signal transduction pathway. J Cell Physiol 2005; 205:437-443.
32. Giannoukakis N, Bonham CA, Qian S etal. Prolongation of cardiac allograft survival using dendritic cells treated with NF-kB decoy oligodeoxyribonucleotides. Mol Ther 2000; 1:430-437.
33. Chen Y, Zhang J, Ge X, Du J, Deb DK, Li YC. Vitamin D receptor inhibits nuclear factor kappaB activation by interacting with IkappaB kinase beta protein. J Biol Chem 2013; 288:19450-19458.
34. Garcia-Cozar FJ, Molina IJ, Cuadrado MJ, Marubayashi M, Pena J, Santamaria M. Defective B7 expression on antigen-presenting cells underlying T cell activation abnormalities in systemic lupus erythematosus (SLE) patients. Clin Exp Immunol 1996; 104:72-79.
35. O'Neill SK, Cao Y, Hamel KM, Doodes PD, Hutas G, Finnegan A. Expression of CD80/86 on B cells is essential for autoreactive T cell activation and the development of arthritis. J Immunol 2007; 179:5109-5116.
36. Wetzel SA, McKeithan TW, Parker DC. Live-cell dynamics and the role of costimulation in immunological synapse formation. J Immunol 2002; 169:6092-6101.
37. Petro TM, Chen SS, Panther RB. Effect of CD80 and CD86 on T cell cytokine production. Immunol Invest 1995; 24:965-976.
38. Mayer E, Holzl M, Ahmadi S etal. CTLA4-Ig immunosuppressive activity at the level of dendritic cell/T cell crosstalk. Int Immunopharmacol 2013; 15:638-645.
39. Pieper J, Herrath J, Raghavan S, Muhammad K, Vollenhoven R, Malmstrom V. CTLA4-Ig (abatacept) therapy modulates T cell effector functions in autoantibody-positive rheumatoid arthritis patients. BMC Immunol 2013; 14:34.
40. Macian F. NFAT proteins: key regulators of T-cell development and function. Nat Rev Immunol 2005; 5:472-484.
41. Diehn M, Alizadeh AA, Rando OJ etal. Genomic expression programs and the integration of the CD28 costimulatory signal in T cell activation. Proc Natl Acad Sci USA 2002; 99:11796-11801.
42. Gett AV, Hodgkin PD. A cellular calculus for signal integration by T cells. Nat Immunol 2000; 1:239-244.
43. Milovanovic M, Heine G, Zuberbier T, Worm M. Allergen extract-induced interleukin-10 in human memory B cells inhibits immunoglobulin E production. Clin Exp Allergy 2009; 39:671-678.
44. Rigby WF, Stacy T, Fanger MW. Inhibition of T lymphocyte mitogenesis by 1, 25-dihydroxyvitamin D3 (calcitriol). J Clin Invest 1984; 74:1451-1455.
45. Joshi S, Pantalena LC, Liu XK etal. 1, 25-dihydroxyvitamin D(3) ameliorates Th17 autoimmunity via transcriptional modulation of interleukin-17A. Mol Cell Biol 2011; 31:3653-3669.